Justera Health Ltd.
SCRSF
$0.0009
-$0.0094-91.26%
| Weiss Ratings | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 7.12 | |||
| Price History | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -91.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -92.97% | |||
| 2-Year Total Return | -91.89% | |||
| 3-Year Total Return | -99.56% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -91.26% | |||
| 52-Week Low % Change | 350.00% | |||
| Price | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | May 03, 2024 | |||
| 52-Week High Price (Date) | Jan 24, 2025 | |||
| Valuation | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 835.50K | |||
| Enterprise Value | 522.61K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -15.12% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.11 | |||
| Price/Book (Q) | -0.05 | |||
| Enterprise Value/Revenue (TTM) | 0.38 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -0.24 | |||
| Enterprise Value/EBIT | -0.24 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 160.81M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 2300 Yonge Street Toronto, ON M4P 1E4 | |||
| Website | www.justerahealth.com | |||
| Country | Canada | |||
| Year Founded | 2020 | |||
| Profitability | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -162.50% | |||
| Profit Margin | -202.25% | |||
| Management Effectiveness | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -54.82% | |||
| Return on Equity | -- | |||
| Income Statement | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.38M | |||
| Total Revenue (TTM) | 1.38M | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | 888.50K | |||
| EBITDA (TTM) | -2.18M | |||
| EBIT (TTM) | -2.24M | |||
| Net Income (TTM) | -2.79M | |||
| Net Income Avl. to Common (TTM) | -2.79M | |||
| Total Revenue Growth (Q YOY) | -9.21% | |||
| Earnings Growth (Q YOY) | -219.30% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -141.79% | |||
| Balance Sheet | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 456.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.43M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -3.07M | |||
| Current Ratio (Q) | 0.317 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 1.56M | |||
| Total Current Liabilities (Q) | 4.50M | |||
| Total Debt (Q) | 122.30K | |||
| Total Liabilities (Q) | 4.63M | |||
| Total Common Equity (Q) | -3.07M | |||
| Cash Flow | SCRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -668.50K | |||
| Cash from Financing (TTM) | 620.20K | |||
| Net Change in Cash (TTM) | -4.70K | |||
| Levered Free Cash Flow (TTM) | 2.02M | |||
| Cash from Operations (TTM) | 43.40K | |||
